3508 results
Type of content
News Remove News filter
-
List item
News: EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants (updated)
Last updated: 07/06/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023 (updated)
CHMP, Last updated: 26/05/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023 (updated)
PRAC, Last updated: 22/05/2023 -
List item
News: Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects (updated)
Last updated: 22/05/2023 -
List item
News: EU recommendations for 2023-2024 seasonal flu vaccine composition
CHMP, Last updated: 04/04/2023 -
List item
News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 2022
CVMP, Last updated: 15/03/2023 -
List item
News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023
CVMP, Last updated: 10/03/2023 -
List item
News: EMA update on shortages of antibiotics in the EU
Last updated: 06/02/2023 -
List item
News: Joint statement by Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on shortages of antibiotic medicines
Last updated: 20/01/2023 -
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
CHMP, Last updated: 13/01/2023 -
List item
News: EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine
CHMP, Last updated: 11/11/2022 -
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
News: EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age
CHMP, Last updated: 19/10/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
CHMP, Last updated: 19/09/2022 -
List item
News: Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan
Last updated: 02/09/2022 -
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market
CMDh, Last updated: 26/07/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines
CHMP, Last updated: 12/11/2021 -
List item
News: Call for expressions of interest for civil society representatives to participate in work of EMA
PRAC, Last updated: 27/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
News: EMA reminds physicians to use Tecentriq with nab-paclitaxel for treating breast cancer
CHMP, Last updated: 21/05/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-29 January 2021
CHMP, Last updated: 01/02/2021 -
List item
News: EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
Last updated: 29/01/2021